MedCap AB (publ) (STO:MCAP)
539.50
+2.00 (0.37%)
Oct 20, 2026, 5:29 PM CET
MedCap AB Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, MedCap AB stock has an average price target of kr 640.00. The average 1-year stock price forecast is 18.63% higher than the current stock price, while the lowest is kr 620.00 (+14.92%) and the highest is kr 660.00 (+22.34%).
Price Target: kr 640.00 (+18.63%)
Analyst Consensus: n/a
Price Target
ChartAnalyst Ratings
According to 1 stock analyst, the rating for MedCap AB is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Oct '25 | Feb '26 | Apr '26 | Jul '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0 | 0 | 0 | 1 | 1 | 1 |
Financial Forecast
Revenue This Year
2.40B
from 2.11B
Increased by 13.69%
Revenue Next Year
2.69B
from 2.40B
Increased by 12.03%
EPS This Year
19.86
from 14.50
Increased by 36.97%
EPS Next Year
24.05
from 19.86
Increased by 21.10%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.